Literature DB >> 31199985

Interplay of interferon-gamma and macrophage polarization during Talaromyces marneffei infection.

Sha Lu1, Dongmei Li2, Liyan Xi3, Richard Calderone4.   

Abstract

Talaromyces marneffei is an increasingly destructive dimorphic fungal pathogen in clinical settings that can cause lethal Talaromycosis. The activation of macrophages is known to be important for host defenses against T. marneffei, and these macrophages are known to be activated in two ways (polarization), known as M1 and M2. We investigated the plasticity of these polarizations, in order to understand if cross-conversion of macrophages may be possible even after they have been programmed. We conducted in vitro experiments using a murine macrophage cell line to investigate the ability of T. marneffei to activate these polarizations. The pre-polarized (M0) macrophage subsets were challenged with LPS as a control, and the sets of M1 markers (iNOS and CD86) and M2 markers (Arg-1 and CD206) were assessed for a possible cross-conversion among M1, M2 and M0 (unstimulated) populations. We found that either conidia or yeast forms of T. marneffei initiate the repression of Arg-1 in M2 cells with no change in the M1 subtype marker molecule iNOS. However, an additional IFN-γ stimulus caused the three macrophage groups to fully exhibit an LPS-induced M2 suppression and a shift to M1 from M0 and M2. We conclude that the conversion of macrophages is required for maintenance of sufficient iNOS production against this organism in the host. The cytokine environment is the key factor that manipulates the plasticity changes among macrophage subtypes. Furthermore, IFN-γ is a crucial host defense factor against pathogenic T. marneffei that has significant therapeutic potential to promote an M1 polarization phenotype.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IFN-γ; Macrophage; Polarization; Talaromyces marneffei

Mesh:

Substances:

Year:  2019        PMID: 31199985     DOI: 10.1016/j.micpath.2019.103594

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  7 in total

1.  Extracellular Vesicles Derived From Talaromyces marneffei Yeasts Mediate Inflammatory Response in Macrophage Cells by Bioactive Protein Components.

Authors:  Biao Yang; Jingyu Wang; Hongye Jiang; Huixian Lin; Zihao Ou; Amir Ullah; Yuneng Hua; Juanjiang Chen; Xiaomin Lin; Xiumei Hu; Lei Zheng; Qian Wang
Journal:  Front Microbiol       Date:  2021-01-08       Impact factor: 5.640

2.  The Effect of Talaromyces marneffei Infection on CD86 Expression in THP-1 Cells.

Authors:  Di Yang; Lin-Xia Shen; Ri-Feng Chen; Yu Fu; Hong-Yan Xu; Li-Na Zhang; Dong-Hua Liu
Journal:  Infect Drug Resist       Date:  2021-02-19       Impact factor: 4.003

3.  Disseminated Coinfection by Mycobacterium fortuitum and Talaromyces marneffei in a Non-HIV Case.

Authors:  Hongchun Huang; Jingmin Deng; Caixia Qin; Jianpeng Zhou; Minchao Duan
Journal:  Infect Drug Resist       Date:  2021-09-07       Impact factor: 4.003

Review 4.  Resolution of Deep Venous Thrombosis: Proposed Immune Paradigms.

Authors:  J Matthew Nicklas; Aviva E Gordon; Peter K Henke
Journal:  Int J Mol Sci       Date:  2020-03-18       Impact factor: 5.923

5.  Cytokine Output of Adipocyte-iNKT Cell Interplay Is Skewed by a Lipid-Rich Microenvironment.

Authors:  Robert J van Eijkeren; Imogen Morris; Anouska Borgman; Angela Markovska; Eric Kalkhoven
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-31       Impact factor: 5.555

Review 6.  Crosstalk between Tumor Cells and Immune System Leads to Epithelial-Mesenchymal Transition Induction and Breast Cancer Progression.

Authors:  Raheleh Moradpoor; Mona Salimi
Journal:  Iran Biomed J       Date:  2020-07-29

7.  Talaromyces marneffei promotes M2-like polarization of human macrophages by downregulating SOCS3 expression and activating the TLR9 pathway.

Authors:  Wudi Wei; Chuanyi Ning; Jiegang Huang; Gang Wang; Jingzhen Lai; Jing Han; Jinhao He; Hong Zhang; Bingyu Liang; Yanyan Liao; Thuy Le; Qiang Luo; Zhen Li; Junjun Jiang; Li Ye; Hao Liang
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.